Notably, NRF2, an anti-inflammatory molecule induced by AKT and AMPK, negatively regulates the activation of NF-κB [68, 69], and its neuroprotective effects have been reported in PD [70]. This evidence concerns the gene AKT1 and Parkinson disease.